CDKN2A and neoplasm: Our observations corroborate previously published findings implicating disruption of the RB1/CDKN2A/TP53 axis in the G1/S phase of the cell cycle and apoptosis checkpoints as an early tumor-initiating event in EGFR-mutant LUADs (50).